SHILPA MEDICARE
|
The Current P/E Ratio of SHILPA MEDICARE is 72.41.
| Share Price | ₹1,012.5 | Sep 25,2026 |
| Market Cap | ₹19,803.5 Cr | |
| Earnings-TTM | ₹273.5 Cr | TTM-Consolidated Results |
| Price/Earnings | 72.41x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of SHILPA MEDICARE
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹19,803.5 Cr] as on Sep 25,2026
(/) Earnings [ ₹273.5 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 72.41x ]
Thus, for SHILPA MEDICARE , the investors are currently willing to pay 72.41 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SHILPA MEDICARE !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SHILPA MEDICARE over the last five years.
Historical PE (Price/Earnings) ratio chart of SHILPA MEDICARE
PE Ratio Performance Analysis for SHILPA MEDICARE
- SHILPA MEDICARE 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 50.38x.
- SHILPA MEDICARE 's operated at median p/e ratio of 41.41x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SHILPA MEDICARE 's p/e ratio peaked in Mar2024 at 125.64x.
- SHILPA MEDICARE 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does SHILPA MEDICARE 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| SHILPA MEDICARE | 273.51 | 72.41 | 19,803.5 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 12,172.70 | 36.53 | 444,717.0 |
| DIVIS LABORATORIES LTD | 2,925.00 | 87.22 | 255,115.0 |
| TORRENT PHARMACEUTICALS LTD | 2,156.00 | 87.95 | 189,613.0 |
| CIPLA LTD | 3,364.84 | 33.55 | 112,876.0 |
| DR REDDYS LABORATORIES LTD | 3,169.30 | 31.68 | 100,395.0 |
| MANKIND PHARMA LTD | 2,055.11 | 49.75 | 102,247.0 |
| LUPIN LTD | 5,551.01 | 17.22 | 95,573.6 |
| ZYDUS LIFESCIENCES LTD | 4,492.20 | 26.69 | 119,900.0 |
| AUROBINDO PHARMA LTD | 3,712.74 | 26.52 | 98,464.4 |
| LAURUS LABS LTD | 1,090.76 | 99.12 | 108,116.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SHILPA MEDICARE 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 17.22x |
| Max industry PE | 99.12x |
| Median industry PE | 36.53x |
| Average industry PE | 51.69x |
You may also like the below Video Courses